PDS Biotechnology (PDSB) Short term Debt (2014 - 2026)
PDS Biotechnology's (PDSB) quarterly Short term Debt came in at $5.1 million in Q4 2025, down 58.96% YoY from $12.5 million in Q4 2024, and down 14.49% on a QoQ basis from $6.0 million in Q3 2025.
PDS Biotechnology (PDSB) Short term Debt (2014 - 2026) Analysis & Trends
PDS Biotechnology (PDSB) has 8 years of Short term Debt data on file, last reported at $5.1 million in Q4 2025.
- Quarterly Short term Debt fell 58.96% year-over-year to $5.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.1 million (down 58.96% YoY) and the FY2025 annual result came in at $5.1 million, down 58.96% from the prior year.
- Short term Debt retreated to $5.1 million in Q4 2025, from $6.0 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $12.5 million in Q3 2024 to a low of $4.2 million in Q4 2023.
- A 3-year average of $8.4 million and a median of $7.3 million in 2024 frame the typical range for Short term Debt.
- Annual changes were most pronounced in 2024 — Short term Debt surged 200.0% — and 2025, when it sank 58.96%.
- Tracing PDSB's Short term Debt over 3 years: stood at $4.2 million in 2023, then surged by 200.0% to $12.5 million in 2024, then slumped by 58.96% to $5.1 million in 2025.
- The last three Short term Debt figures came in at $5.1 million (Q4 2025), $6.0 million (Q3 2025), and $5.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | PDS Biotechnology | 12.71 Mn | 12.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Mn |
| Dec 31, 2025 | 5.13 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 5.50 Mn |
| Mar 31, 2025 | 12.50 Mn |
| Dec 31, 2024 | 12.50 Mn |
| Sep 30, 2024 | 12.50 Mn |
| Jun 30, 2024 | 10.42 Mn |
| Mar 31, 2024 | 7.29 Mn |
| Dec 31, 2023 | 4.17 Mn |
| Mar 31, 2018 | 20.90 Mn |
| Dec 31, 2017 | 3.08 Mn |
| Sep 30, 2017 | 5.45 Mn |
| Jun 30, 2017 | 3.09 Mn |
| Mar 31, 2017 | 579,554.00 |
| Jun 30, 2016 | 2.39 Mn |
| Mar 31, 2016 | 2.33 Mn |
| Dec 31, 2015 | 2.27 Mn |
| Sep 30, 2015 | 2.21 Mn |
| Dec 31, 2014 | 265,265.00 |